Wu, J., Yang, K., Fan, H., Wei, M
This is the same approach used in all chronic diseases eg diabetes management is more than just lowering glucose levels
You might absorb 90% of the dose from healthy tissue and only 50% from scarred tissue, creating the kind of inconsistency that undermines predictable results
Customized Targeting with an Omni-Channel Reach
The disclosure that matters is that I think the consumer category it represents is going to be one of the more significant pharmaceutical-adjacent industries of the next decade, and the way it is going to play out is structurally different from anything the pharma industry or its regulators have dealt with before.
Body composition represents one of the most significant determinants of metabolic rate